0001193125-17-043592.txt : 20170214 0001193125-17-043592.hdr.sgml : 20170214 20170214165634 ACCESSION NUMBER: 0001193125-17-043592 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 GROUP MEMBERS: CHRISTOPHER A. WHITE GROUP MEMBERS: CLARKE B. FUTCH GROUP MEMBERS: HCRP MGS ACCOUNT MANAGEMENT, LLC GROUP MEMBERS: HCRP OVERFLOW FUND, L.P. GROUP MEMBERS: HCRP OVERFLOW GP, LLC GROUP MEMBERS: HEALTHCARE ROYALTY GP III, LLC GROUP MEMBERS: HEALTHCARE ROYALTY MANAGEMENT, LLC GROUP MEMBERS: MATTHEW Q. REBER GROUP MEMBERS: MICHAEL G. CARTER GROUP MEMBERS: MOLAG HEALTHCARE ROYALTY, LLC GROUP MEMBERS: PAUL J. HADDEN GROUP MEMBERS: VANDERBILT ACCOUNT MANAGEMENT GP, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88402 FILM NUMBER: 17609915 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE ROYALTY PARTNERS III, L.P. CENTRAL INDEX KEY: 0001582018 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 300 ATLANTIC STREET STREET 2: SUITE 600 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203.388.9080 MAIL ADDRESS: STREET 1: 300 ATLANTIC STREET STREET 2: SUITE 600 CITY: STAMFORD STATE: CT ZIP: 06901 SC 13G/A 1 d321300dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 Schedule 13G Amendment No. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Amendment No. 1)*

Under the Securities Exchange Act of 1934

 

 

Coherus BioSciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

19249H103

(CUSIP Number)

December 31, 2016

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

HealthCare Royalty Partners III, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

1,677,701

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

1,677,701

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,677,701

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

3.6%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

PN

 

 

Page 2 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

HealthCare Royalty GP III, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

1,677,701

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

1,677,701

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,677,701

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

3.6%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

OO

 

 

Page 3 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

HCRP Overflow Fund, L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

1,118,468

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

1,118,468

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,118,468

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

2.4%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

PN

 

 

Page 4 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

HCRP Overflow GP, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

1,118,468

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

1,118,468

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,118,468

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

2.4%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

OO

 

 

Page 5 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

MOLAG Healthcare Royalty, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

559,234

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

559,234

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

559,234

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.2%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

OO

 

 

Page 6 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

HCRP MGS Account Management, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

559,234

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

559,234

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

559,234

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.2%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IA

 

 

Page 7 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Vanderbilt Account Management GP, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

559,234

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

559,234

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

559,234

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

1.2%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

OO

 

 

Page 8 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Healthcare Royalty Management, LLC

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

2,796,169

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

2,796,169

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,796,169

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.9%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IA

 

 

Page 9 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Clarke B. Futch

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

3,355,402

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

3,355,402

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,355,402

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

7.1%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

Page 10 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Paul J. Hadden

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

2,796,169

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

2,796,169

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,796,169

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.9%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

Page 11 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Matthew Q. Reber

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

2,796,169

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

2,796,169

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,796,169

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.9%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

Page 12 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Christopher A. White

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

2,796,169

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

2,796,169

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,796,169

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.9%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

Page 13 of 21


CUSIP No. 19249H103          

 

  1   

NAME OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 

Michael G. Carter

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐        (b)  ☒

 

  3  

SEC USE ONLY

 

    

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United Kingdom

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

0

   6   

SHARED VOTING POWER

 

2,796,169

   7   

SOLE DISPOSITIVE POWER

 

0

   8   

SHARED DISPOSITIVE POWER

 

2,796,169

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,796,169

10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)  ☐

 

    

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.9%

12  

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

Page 14 of 21


CUSIP No. 19249H103          

 

Item 1.    (a)    Name of Issuer
      Coherus BioSciences, Inc.
   (b)    Address of Issuer’s Principal Executive Offices
      333 Twin Dolphin Drive
      Suite 600
      Redwood City, CA 94065
Item 2.    (a)    Name of Person Filing
      This Amendment No. 1 to Schedule 13G is being filed on behalf of the following:
      HealthCare Royalty Partners III, L.P.
      HealthCare Royalty GP III, LLC
      HCRP Overflow Fund, L.P.
      HCRP Overflow GP, LLC
      MOLAG Healthcare Royalty, LLC
      HCRP MGS Account Management, LLC
      Vanderbilt Account Management GP, LLC
      HealthCare Royalty Management, LLC
      Clarke B. Futch
      Paul J. Hadden
      Matthew Q. Reber
      Christopher A. White
      Michael G. Carter
   (b)    Address of Principal Business Office, or if none, Residence:
      The address of the principal business office of the reporting persons is:
      300 Atlantic Street, Suite 600
      Stamford, CT 06901
   (c)    Citizenship:
      The place of organization of HealthCare Royalty Partners III, L.P., HealthCare Royalty GP III, LLC, HCRP Overflow Fund, L.P., HCRP Overflow GP, LLC, MOLAG Healthcare Royalty, LLC, HCRP MGS Account Management, LLC Vanderbilt Account Management GP, LLC and HealthCare Royalty Management, LLC is Delaware. Messrs. Futch, Hadden, Reber and White are each citizens of the United States, and Mr. Carter is a citizen of the United Kingdom.
   (d)    Title of Class of Securities
      Common stock, par value $0.0001 per share
   (e)    CUSIP Number
      19249H103
Item 3.    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
      Not Applicable

 

Page 15 of 21


CUSIP No. 19249H103

         

 

Item 4. Ownership.

 

Reporting Person

   (a)
Amount
beneficially
owned:
     (b)
Percent of
class(1):
    (c)(i)
Sole
power to

vote or
direct

the vote:
     (c)(ii)
Shared
power to
vote

or to
direct
the vote
     (c)(iii)
Sole
power to

dispose or
to

direct the
disposition
of:
     (c)(iv)
Shared
power to
dispose or
direct the
disposition
of:
 

HealthCare Royalty Partners III, L.P.

     1,677,701         3.6     0         1,677,701         0         1,677,701   

HealthCare Royalty GP III, LLC(2)

     1,677,701         3.6     0         1,677,701         0         1,677,701   

HCRP Overflow Fund, L.P.

     1,118,468         2.4     0         1,118,468         0         1,118,468   

HCRP Overflow GP, LLC(3)

     1,118,468         2.4     0         1,118,468         0         1,118,468   

MOLAG Healthcare Royalty, LLC

     559,234         1.2     0         559,234         0         559,234   

HCRP MGS Account Management, LLC(4)

     559,234        1.2     0         559,234        0         559,234  

Vanderbilt Account Management GP, LLC(5)

     559,234         1.2     0         559,234         0         559,234   

HealthCare Royalty Management, LLC(6)

     2,796,169         5.9     0         2,796,169         0         2,796,169   

Clarke B. Futch(7)(8)

     3,355,403         7.1     0         3,355,403         0         3,335,403   

Paul J. Hadden(7)

     2,796,169         5.9     0         2,796,169         0         2,796,169   

Matthew Q. Reber(7)

     2,796,169         5.9     0         2,796,169         0         2,796,169   

Christopher A. White(7)

     2,796,169        5.9     0         2,796,169        0         2,796,169  

Michael G. Carter(7)

     2,796,169         5.9     0         2,796,169         0         2,796,169   

 

(1) Based upon 43,652,743 shares of Common Stock outstanding as of October 31, 2016, as reported in the Issuer’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016, plus 3,355,403 shares of Issuer’s common stock that are subject to the Notes that are convertible at any time at the option of the Holders (as defined below).
(2) In its capacity as general partner of HealthCare Royalty Partners III, L.P.
(3) In its capacity as general partner of HCRP Overflow Fund, L.P.
(4) In its capacity as investment manager of MOLAG Healthcare Royalty, LLC
(5) In its capacity as the managing member of HCRP MGS Account Management, LLC
(6) In its capacity as investment manager of each of HealthCare Royalty GP II, LLC and HCRP Overflow GP, LLC.
(7) In his capacity as a member of the investment committee that, through HealthCare Royalty Management, LLC, is responsible for the voting and investment decisions relating to the shares beneficially owned by the HCRP Holders (as defined below).
(8) In his capacity as the sole member of the operating committee that, through Vanderbilt Account Management GP, LLC, is responsible for the voting and investment committee decisions relating to the shares beneficially owned by MOLAG Healthcare (as defined below).

All of the shares of Common Stock beneficially owned or that may be deemed to be beneficially owned by the reporting persons are issuable upon conversion of the Issuer’s 8.2% Senior

 

Page 16 of 21


CUSIP No. 19249H103          

 

Convertible Notes due 2022 (the “Notes”). The Notes are held by HealthCare Royalty Partners III, L.P. (“HCRP III”), HCRP Overflow Fund, L.P. (“HCRP Overflow”, and together with HCRP III, the “HCRP Holders”) and MOLAG Healthcare Royalty, LLC (“MOLAG Healthcare”, and together with the HCRP Holders, the “Holders”). Each Holder may convert the Notes at the Holder’s option on any day prior to the close of business on the business day immediately preceding March 31, 2022 into shares of Common Stock at an initial conversion rate of 44.7387 shares of Common Stock (plus cash in lieu of any fractional shares) per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of $22.35 per share and is subject to adjustment in certain events described in the Convertible Note Purchase Agreement, dated as of February 29, 2016, by and among HCRP III, the Issuer, the guarantors named therein and the investors named therein.

HealthCare Royalty GP III, LLC is the general partner of HCRP III and therefore may be deemed to beneficially own the shares beneficially owned by HCRP III. HCRP Overflow GP, LLC is the general partner of HCRP Overflow and therefore may be deemed to beneficially own the shares beneficially owned by HCRP Overflow. HealthCare Royalty Management, LLC is the investment manager of each of HealthCare Royalty GP II, LLC and HCRP Overflow GP, LLC and therefore may be deemed to beneficially own the shares beneficially owned by the HCRP Holders. Clarke B. Futch, Paul J. Hadden, Matthew Q. Reber, Christopher A. White and Michael G. Carter comprise the investment committee that, through HealthCare Royalty Management, LLC, is responsible for the voting and investment decisions relating to the shares beneficially owned by the HCRP Holders. HCRP MGS Account Management, LLC is the investment manager of MOLAG Healthcare and therefore may be deemed to beneficially own the shares held by MOLAG Healthcare. Vanderbilt Account Management GP, LLC is managing member of HCRP MGS Account Management, LLC and therefore may be deemed to beneficially own the shares beneficially owned by MOLAG Healthcare. Clarke B. Futch comprises the operating committee that, through Vanderbilt Account Management GP, LLC, is responsible for the voting and investment committee decisions relating to the shares beneficially owned by MOLAG Healthcare. The HCRP Holders and MOLAG Healthcare may be deemed to be a group as defined in Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended, and each member of such group may be deemed to beneficially own the ordinary shares beneficially owned by other members constituting such group. Each of Messrs. Futch, Hadden, Reber, White and Carter disclaims beneficial ownership of all shares of common stock of the Issuer included in this report. The filing of this Amendment No. 1 to Schedule 13G should not be deemed an admission that any of Messrs. Futch, Hadden, Reber, White and Carter is the beneficial owner of such shares for any purpose.

 

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☐

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

Not applicable.

 

Page 17 of 21


CUSIP No. 19249H103          

 

Item 9. Notice of Dissolution of Group.

Not applicable.

 

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

 

Page 18 of 21


CUSIP No. 19249H103          

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2017

 

HEALTHCARE ROYALTY PARTNERS III, L.P.
By:   HealthCare Royalty GP III, LLC, its general partner
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HEALTHCARE ROYALTY GP III, LLC, as general partner of HealthCare Royalty Partners III, L.P.
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HCRP OVERFLOW FUND, L.P.
By:   HCRP Overflow GP, LLC, its general partner
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HCRP OVERFLOW GP, LLC, as general partner of HCRP Overflow Fund, L.P.
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
MOLAG HEALTHCARE ROYALTY, LLC.
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner

HCRP MGS ACCOUNT MANAGEMENT, LLC, as investment management of Molag Healthcare Royalty, LLC

By:   Vanderbilt Account Management GP, LLC, its managing member
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner

 

Page 19 of 21


CUSIP No. 19249H103          

 

VANDERBILT ACCOUNT MANAGEMENT GP, LLC
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HEALTHCARE ROYALTY MANAGEMENT, LLC, as investment manager of HealthCare Royalty GP III, LLC and HCRP Overflow GP, LLC
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner

/s/ Clarke B. Futch            

Name:   Clarke B. Futch
Title:   Managing Partner, HealthCare Royalty
  Management, LLC

/s/ Paul J. Hadden            

Name:   Paul J. Hadden
Title:   Managing Director, HealthCare Royalty
  Management, LLC

/s/ Matthew Q. Reber            

Name:   Matthew Q. Reber
Title:   Managing Director, HealthCare Royalty
  Management, LLC

/s/ Christopher A. White

Name:   Christopher A. White
Title:   Chief Operating Officer, HealthCare Royalty
  Management, LLC

/s/ Michael G. Carter

Name:   Michael G. Carter
Title:   Investment Committee Member, HealthCare Royalty Management, LLC

 

Page 20 of 21


CUSIP No. 19249H103          

 

Exhibit Description

 

A Joint Filing Agreement

 

Page 21 of 21

EX-99.A 2 d321300dex99a.htm EX-99.A EX-99.A
CUSIP No. 19249H103          

 

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share of Coherus BioSciences, Inc., and that this agreement may be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned hereby execute this agreement as of February 14, 2017.

 

HEALTHCARE ROYALTY PARTNERS III, L.P.
By:   HealthCare Royalty GP III, LLC, its general partner
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HEALTHCARE ROYALTY GP III, LLC, as general partner of HealthCare Royalty Partners III, L.P.
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HCRP OVERFLOW FUND, L.P.
By:   HCRP Overflow GP, LLC, its general partner
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HCRP OVERFLOW GP, LLC, as general partner of HCRP Overflow Fund, L.P.
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
MOLAG HEALTHCARE ROYALTY, LLC
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner

 

Page 1 of 2


CUSIP No. 19249H103          

 

HCRP MGS ACCOUNT MANAGEMENT, LLC, as investment management of MOLAG Healthcare Royalty, LLC

By:   Vanderbilt Account Management GP, LLC, its managing member
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
VANDERBILT ACCOUNT MANAGEMENT GP, LLC
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner
HEALTHCARE ROYALTY MANAGEMENT, LLC, as investment manager of HealthCare Royalty GP III, LLC and HCRP Overflow GP, LLC
By:  

/s/ Clarke B. Futch

  Clarke B. Futch
  Managing Partner

/s/ Clarke B. Futch

Name:   Clarke B. Futch
Title:   Managing Partner, HealthCare Royalty
  Management, LLC

/s/ Paul J. Hadden

Name:   Paul J. Hadden
Title:   Managing Director, HealthCare Royalty
  Management, LLC

/s/ Matthew Q. Reber

Name:   Matthew Q. Reber
Title:   Managing Director, HealthCare Royalty
  Management, LLC

/s/ Christopher A. White

Name:   Christopher A. White
Title:   Chief Operating Officer, HealthCare Royalty
  Management, LLC

/s/ Michael G. Carter

Name:   Michael G. Carter
Title:   Investment Committee Member, HealthCare Royalty Management, LLC

 

Page 2 of 2